to page content
to site navigation
Explore the Entrepreneurship.org Resource Center to find resources. Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. He formed the first
Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 90 Life Sciences
companies which are developing hundreds of products to treat major underserved medical needs representing huge markets in the nearly two trillion dollar healthcare sector. Brook was the founding President and then Chairman of four
biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion. He is currently on the Board of Directors of eight companies, most recently joining
CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, Nanofluidics and XDx, Inc.. He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals,
Pharmacopeia, Ligand Pharmaceuticals (Chairman), Hybritech (Chairman), Genprobe, Nanogen, and others. These companies have pioneered the medical uses of molecular biology, monoclonal antibodies, molecular diagnostics and genomics. Brook
was President and a Director of the Western Association of Venture Capitalists and is a contributing author to the book "Guide to Venture Capital". He is currently a Board member of the University of California at San Francisco Medical
Foundation, the California Healthcare Institute, the New Schools Foundation, Stanford's Bio-X Advisory Council, the Stanford Eye Council and TechNet. He is Co-Chair of the current five year, $1.4 billion, UCSF Capital Campaign. He was
formerly a Director of the Entrepreneurs Foundation, t
John Doerr joined Intel in 1974 just as they invented the famous "8080" 8 bit microprocessor. At Intel, he held various engineering, marketing and management assignments, and was one of their top-ranked sales executives.
In 1980, he joined Kleiner Perkins Caufield & Byers and sponsored a series of investments including Compaq, Cypress, Intuit, Macromedia, Netscape, Lotus, Millennium Pharmaceuticals, S3, Sun Microsystems, Amazon.com, and Symantec. John
was the founding CEO of Silicon Compilers and currently serves on the Board of Directors of Google, Intuit, Amazon.com, Homestore.com, and Sun Microsystems. His privately held company board seats include Good Technology, and Segway. He
holds patents for computer memory devices he invented as a design engineer at Monsanto. Recent interests include education, the Internet and biotechnology genomics. John was born one of five children and raised in St. Louis, Missouri. He
holds a BS and MS in Electrical Engineering from Rice University and an MBA from the Harvard Graduate School of Business Administration.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
A robust online curriculum for entrepreneurs.
Explore Founders School >
A network of U.S. cities facilitating a weekly entrepreneur education program. Go to 1 Million Cups >
Whether you are starting or growing a company, FastTrac will help you live your dream at each stage.
Get started with FastTrac >